LPTX icon

Leap Therapeutics
LPTX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $3.93M invested in Leap Therapeutics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$962K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.13M
2
+$129K
3
+$108K
4
BlackRock
BlackRock
New York
+$16.4K
5
VF
Virtu Financial
New York
+$7.85K

Top Sellers

1
-$340K
2
-$326K
3
-$248K
4
DS
DRW Securities
Illinois
-$101K
5
SIM
Spark Investment Management
New York
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.92M
2
$366K
3
$281K
4
$200K
5
$68K
6
$45K
7
$34K
8
$11K
9
$3K
10
$1K
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–